Regulatory & BiostatisticsFounded 2008
Certara, Inc.
Radnor, Pennsylvania, USA
Publicly traded (Nasdaq: CERT) biosimulation and regulatory science company that pairs modeling-and-simulation software (PK/PD, quantitative systems pharmacology) with consulting, regulatory writing, and submission-support services, helping drug developers design trials, justify dosing, and prepare filings for agencies like FDA and EMA.
- Segment
- Regulatory & Biostatistics
- Headquarters
- Radnor, Pennsylvania, USA
- Founded
- 2008
- Website
- www.certara.com
Notable facts
- Formed December 11, 2008 through a Vector Capital-led merger of Tripos (cheminformatics/molecular modeling) and Pharsight Corporation (clinical trial simulation and PK software).
- Relocated its global corporate headquarters from Princeton, NJ to Radnor, PA in April 2024.
- Acquired AUTHOR!, a regulatory-and-biostatistics services firm based in Europe, expanding its regulatory writing/biostatistics bench.
- Company materials state over 1,550 employees across 30+ countries and citation of its tools in more than 33,000 peer-reviewed publications (self-reported by Certara, not independently verified).
Sourcing guides
Sources. This profile is compiled from public reference data, WebSearch-verified against source 1 · source 2 · source 3. Data as of 2026-07-14. See methodology.
Sourcing a vendor in this segment today? We connect clinical operations, regulatory, and procurement teams with qualified regulatory & biostatistics vendors.
Request vendors